The bill amends Chapter 5-19.1 of the General Laws, titled "Pharmacies," by introducing a new section, 5-19.1-37, which allows pharmacists to dispense a one-time refill of a prescription for the continuation of therapy under specific conditions. This provision applies when a pharmacist cannot obtain refill authorization from the prescriber or when the patient lacks a prescriber. The refill can be for up to 100 days of the prescribed medication, provided that the medication is not classified as a Schedule II-V controlled substance, is essential for maintaining life or managing a chronic condition, and that the pharmacist believes that interrupting the therapy could lead to negative health outcomes. Additionally, the pharmacist must notify the prescriber of the refill within seven business days, or document the absence of a prescriber if applicable.

The act is set to take effect on July 1, 2025, and aims to ensure that patients can continue their necessary medications without interruption, thereby promoting better health outcomes. This legislative change reflects a response to the challenges faced by patients who may encounter difficulties in obtaining timely prescription refills.